da Silva-Junior Geraldo Prisco, de Almeida Souza Liane Maciel, Groppo Francisco Carlos
Dental School of Federal University of Sergipe.
Piracicaba Dental School, University of Campinas.
Anesth Prog. 2017 Summer;64(2):80-84. doi: 10.2344/anpr-64-02-06.
In order to compare the efficacy of lidocaine and articaine for pain control during third molar surgery, 160 patients presenting bilateral asymptomatic impacted mandibular third molars were selected. They received 1.8 mL of 2% lidocaine with epinephrine 1:100,000 during inferior alveolar nerve block. In group 1 (n = 80), an infiltrative injection of 0.9 mL of 2% lidocaine with epinephrine 1:100,000 was performed in buccal-distal mucosa of the third molar. Group 2 (n = 80) received 0.9 mL of 4% articaine with epinephrine 1:100,000 in the contralateral side. All procedures were performed at the same visit, by a single operator, in a double-blind and parallel design. The duration of each surgery and the moment when the patient expressed pain were noted. Data were analyzed by nonpaired t test and chi-square test (alpha = 5%). Duration of surgery did not differ (p = .83) between Groups 1 (19.8 ± 2.3 minutes) and 2 (19.7 ± 3.0 minutes). Pain was expressed more in group 1 (26.3%) than in group 2 (10%) (odds ratio = 3.2, p = .0138). In both groups, tooth sectioning was the most painful event (p < .0001). No influence of gender (p = .85) or age (p = .96) was observed in pain response. Buccal infiltration of 4% articaine with epinephrine 1:100,000 showed more efficacy than 2% lidocaine with epinephrine 1:100,000 when used in combination with inferior alveolar nerve block in controlling intraoperative pain related to impacted mandibular third molar surgery.
为比较利多卡因和阿替卡因在下颌第三磨牙手术中控制疼痛的疗效,选取了160例双侧无症状下颌阻生第三磨牙患者。在下牙槽神经阻滞时,他们接受了1.8毫升含1:100,000肾上腺素的2%利多卡因。在第1组(n = 80)中,在第三磨牙颊侧远中黏膜处浸润注射0.9毫升含1:100,000肾上腺素的2%利多卡因。第2组(n = 80)在对侧接受0.9毫升含1:100,000肾上腺素的4%阿替卡因。所有操作均在同一次就诊时由单一操作者采用双盲平行设计进行。记录每次手术的持续时间以及患者表示疼痛的时刻。数据采用非配对t检验和卡方检验进行分析(α = 5%)。第1组(19.8 ± 2.3分钟)和第2组(19.7 ± 3.0分钟)的手术持续时间无差异(p = 0.83)。第1组(26.3%)的疼痛发生率高于第2组(10%)(优势比 = 3.2,p = 0.0138)。在两组中,牙齿切割是最疼痛的事件(p < 0.0001)。未观察到性别(p = 0.85)或年龄(p = 0.96)对疼痛反应有影响。在与下牙槽神经阻滞联合用于控制下颌阻生第三磨牙手术相关的术中疼痛时,含1:100,000肾上腺素的4%阿替卡因颊侧浸润显示出比含1:100,000肾上腺素的2%利多卡因更高的疗效。